Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C
As part of our ongoing studies on the potential pathophysiological role of serine/threonine phosphatases (PP) in the mammalian heart, we have generated mice with cardiac-specific overexpression of PP2Cβ (PP2C-TG) and compared them with littermate wild type mice (WT) serving as a control. Cardiac fib...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.591773/full |
id |
doaj-b021743755d641a393a09eb53a4cce6f |
---|---|
record_format |
Article |
spelling |
doaj-b021743755d641a393a09eb53a4cce6f2021-02-01T13:14:45ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-01-011110.3389/fphar.2020.591773591773Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2CPaula Bollmann0Franziska Werner1Marko Jaron2Tom A. Bruns3Hartmut Wache4Jochen Runte5Peter Boknik6Uwe Kirchhefer7Frank U. Müller8Igor B. Buchwalow9Sven Rothemund10Joachim Neumann11Ulrich Gergs12Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Westfälische Wilhelms-Universität, Münster, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Westfälische Wilhelms-Universität, Münster, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Westfälische Wilhelms-Universität, Münster, GermanyInstitute for Hematopathology, Hamburg, GermanyIZKF Leipzig, Leipzig, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, GermanyAs part of our ongoing studies on the potential pathophysiological role of serine/threonine phosphatases (PP) in the mammalian heart, we have generated mice with cardiac-specific overexpression of PP2Cβ (PP2C-TG) and compared them with littermate wild type mice (WT) serving as a control. Cardiac fibrosis was noted histologically in PP2C-TG. Collagen 1a, interleukin-6 and the natriuretic peptides ANP and BNP were augmented in PP2C-TG vs. WT (p < 0.05). Left atrial preparations from PP2C-TG were less resistant to hypoxia than atria from WT. PP2C-TG maintained cardiac function after the injection of lipopolysaccharide (LPS, a model of sepsis) and chronic isoproterenol treatment (a model of heart failure) better than WT. Crossbreeding of PP2C-TG mice with PP2A-TG mice (a genetic model of heart failure) resulted in double transgenic (DT) mice that exhibited a pronounced increase of heart weight in contrast to the mild hypertrophy noted in the mono-transgenic mice. The ejection fraction was reduced in PP2C-TG and in PP2A-TG mice compared with WT, but the reduction was the highest in DT compared with WT. PP2A enzyme activity was enhanced in PP2A-TG and DT mice compared with WT and PP2C-TG mice. In summary, cardiac overexpression of PP2Cβ and co-overexpression of both the catalytic subunit of PP2A and PP2Cβ were detrimental to cardiac function. PP2Cβ overexpression made cardiac preparations less resistant to hypoxia than WT, leading to fibrosis, but PP2Cβ overexpression led to better adaptation to some stressors, such as LPS or chronic β-adrenergic stimulation. Hence, the effect of PP2Cβ is context sensitive.https://www.frontiersin.org/articles/10.3389/fphar.2020.591773/fulltransgenic micePP2APP2Cheart failurefibrosisinflammation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Paula Bollmann Franziska Werner Marko Jaron Tom A. Bruns Hartmut Wache Jochen Runte Peter Boknik Uwe Kirchhefer Frank U. Müller Igor B. Buchwalow Sven Rothemund Joachim Neumann Ulrich Gergs |
spellingShingle |
Paula Bollmann Franziska Werner Marko Jaron Tom A. Bruns Hartmut Wache Jochen Runte Peter Boknik Uwe Kirchhefer Frank U. Müller Igor B. Buchwalow Sven Rothemund Joachim Neumann Ulrich Gergs Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C Frontiers in Pharmacology transgenic mice PP2A PP2C heart failure fibrosis inflammation |
author_facet |
Paula Bollmann Franziska Werner Marko Jaron Tom A. Bruns Hartmut Wache Jochen Runte Peter Boknik Uwe Kirchhefer Frank U. Müller Igor B. Buchwalow Sven Rothemund Joachim Neumann Ulrich Gergs |
author_sort |
Paula Bollmann |
title |
Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C |
title_short |
Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C |
title_full |
Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C |
title_fullStr |
Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C |
title_full_unstemmed |
Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C |
title_sort |
initial characterization of stressed transgenic mice with cardiomyocyte-specific overexpression of protein phosphatase 2c |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2021-01-01 |
description |
As part of our ongoing studies on the potential pathophysiological role of serine/threonine phosphatases (PP) in the mammalian heart, we have generated mice with cardiac-specific overexpression of PP2Cβ (PP2C-TG) and compared them with littermate wild type mice (WT) serving as a control. Cardiac fibrosis was noted histologically in PP2C-TG. Collagen 1a, interleukin-6 and the natriuretic peptides ANP and BNP were augmented in PP2C-TG vs. WT (p < 0.05). Left atrial preparations from PP2C-TG were less resistant to hypoxia than atria from WT. PP2C-TG maintained cardiac function after the injection of lipopolysaccharide (LPS, a model of sepsis) and chronic isoproterenol treatment (a model of heart failure) better than WT. Crossbreeding of PP2C-TG mice with PP2A-TG mice (a genetic model of heart failure) resulted in double transgenic (DT) mice that exhibited a pronounced increase of heart weight in contrast to the mild hypertrophy noted in the mono-transgenic mice. The ejection fraction was reduced in PP2C-TG and in PP2A-TG mice compared with WT, but the reduction was the highest in DT compared with WT. PP2A enzyme activity was enhanced in PP2A-TG and DT mice compared with WT and PP2C-TG mice. In summary, cardiac overexpression of PP2Cβ and co-overexpression of both the catalytic subunit of PP2A and PP2Cβ were detrimental to cardiac function. PP2Cβ overexpression made cardiac preparations less resistant to hypoxia than WT, leading to fibrosis, but PP2Cβ overexpression led to better adaptation to some stressors, such as LPS or chronic β-adrenergic stimulation. Hence, the effect of PP2Cβ is context sensitive. |
topic |
transgenic mice PP2A PP2C heart failure fibrosis inflammation |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2020.591773/full |
work_keys_str_mv |
AT paulabollmann initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT franziskawerner initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT markojaron initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT tomabruns initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT hartmutwache initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT jochenrunte initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT peterboknik initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT uwekirchhefer initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT frankumuller initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT igorbbuchwalow initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT svenrothemund initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT joachimneumann initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c AT ulrichgergs initialcharacterizationofstressedtransgenicmicewithcardiomyocytespecificoverexpressionofproteinphosphatase2c |
_version_ |
1724315426644557824 |